Clinical Trials Browser

Active not recruiting × Lorazepam × 1 year × Clear all

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT03743649 2025-12-26

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

Phase 2/3 Active not recruiting

Delirium, Neoplasm Metastasis, Recurrence